TCL Archive Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds. December 14, 2001
TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010